Hyperbaric oxygen therapy for carcinoma of the cervix—Stages IIB, IIIA, IIIB and IVA: Results of a randomized study by the radiation therapy oncology group-Reference-Cited by-同舟云学术

Hyperbaric oxygen therapy for carcinoma of the cervix—Stages IIB, IIIA, IIIB and IVA: Results of a randomized study by the radiation therapy oncology group

Published:1981-08 Issue:8 Volume:7 Page:991-998
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Brady Luther W.,Plenk Henry P.,Hanley James A.,Glassburn John R.,Kramer Simon,Parker Robert G.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference16 articles.

1. High pressure oxygen and radiotherapy;Churchill-Davidson;Lancet,1955

2. Clinical trials with Hperbaric oxygen in radiotherapy. Oncology 1970;Dische,1971

3. Hyperbaric oxygen—The medical research council trials and their clinical significance;Dische;Br. J. Radiol.,1978

4. Hyperbaric oxygen as a radiotherapeutic adjuvant in advanced cancer of the uterine cervix;Fletcher;Cancer,1977

5. Hyperbaric oxygen in radiotherapy;Glassburn;Cancer,1977

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hyperbaric oxygenation for tumour sensitisation to radiotherapy;Cochrane Database of Systematic Reviews;2018-04-11

2. NMR diffusion and relaxation studies of 2-nitroimidazole and albumin interactions;Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy;2018-03

3. Role of histopathological differentiation as a prognostic factor for treatment response in locally advanced squamous cell carcinoma cervix patients;Indian Journal of Medical and Paediatric Oncology;2018

4. Radiation Therapy Oncology Group Gynecologic Oncology Working Group: Comprehensive Results;International Journal of Gynecologic Cancer;2014-06

5. Concurrent chemoradiation versus radiotherapy alone in cervical carcinoma: A randomized phase III trial;Asia-Pacific Journal of Clinical Oncology;2013-05-27